Your browser doesn't support javascript.
loading
The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study.
Yonemori, Kan; Shimizu, Toshio; Kondo, Shunsuke; Iwasa, Satoru; Koyama, Takafumi; Kitano, Shigehisa; Sato, Jun; Shimomura, Akihiko; Shibaki, Ryota; Suri, Ajit; Kase, Yoichi; Sumino, Shuuji; Tamura, Kenji; Yamamoto, Noboru.
Affiliation
  • Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Iwasa S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Kitano S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Sato J; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Shimomura A; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Shibaki R; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Suri A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kase Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
  • Sumino S; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Tamura K; Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Yamamoto N; Takeda Pharmaceutical Company Limited, Osaka, Japan.
Jpn J Clin Oncol ; 51(5): 693-699, 2021 Apr 30.
Article in En | MEDLINE | ID: mdl-33621324
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Poly(ADP-ribose) Polymerase Inhibitors / Indazoles / Neoplasms Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Jpn J Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Poly(ADP-ribose) Polymerase Inhibitors / Indazoles / Neoplasms Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Jpn J Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: